Odds ratio (OR) for depression (HADS-D>=8) with 95% confidence interval (CI). Analyses are run using the weighted survey design on the sub-sample with non-missing for all included... by Maria Lage Barca (4515385)

Subjects:

Potential reduction in number (and %) with depression in the Norwegian 70 + population for year 2023 in the scenarios where loneliness is reduced by 10%, 20%, 30%, 40%, 50%, and 10... by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence* HADS-D>=8 with 95% CI by sex, time, age group, and living situation. by Maria Lage Barca (4515385)

Subjects:

Standardized** prevalence of depression (HADS-D>=8) with 95% CI by sex and year, age 70 + . by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence of depression (HADS-D>=8 with 95% CI) by sex, time, and age group. by Maria Lage Barca (4515385)

Subjects:

Standardized prevalence* of depression (HADS-D>=8) with 95% CI by sex, age, and self-reported loneliness. by Maria Lage Barca (4515385)

Subjects:

Projections of total number of 70 + yr olds with depression (HADS-D>=8) in Norway for years 2025, 2030, 2035, 2040, 2045, 2050, and 2100. by Maria Lage Barca (4515385)

Subjects:

Sample characteristics among older adults with and without depression (HADS-D>=8) in HUNT2-4. N = 26,512. The HUNT Study, Norway. by Maria Lage Barca (4515385)

Subjects:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)

Time evolution trend of green finance level. by Dalai Ma (17847101)

“…The findings indicate that: (1) The level of GF demonstrates a rising trajectory, with significant regional disparities. Besides, the high level area progressively moves from the northwest to the southwest. (2) On the whole, urban EE demonstrates a relatively elevated level, but it still fails to reach DEA effectiveness. …”

Spatial evolution trend of green finance index. by Dalai Ma (17847101)

“…The findings indicate that: (1) The level of GF demonstrates a rising trajectory, with significant regional disparities. Besides, the high level area progressively moves from the northwest to the southwest. (2) On the whole, urban EE demonstrates a relatively elevated level, but it still fails to reach DEA effectiveness. …”

IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10⁷ CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated... by Midhun Sebastian Jose (19336846)

CTL response following combination therapy with NDV. by Hedieh Zargaran (21410233)